• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number SP-101
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Hypersensitivity/Allergic reaction (1907); Itching Sensation (1943)
Event Date 04/23/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician used a venaseal occluding device during procedure to treat bilateral great saphenous vein (gsv).Approximately one month post procedure, there was no symptom after the procedure, but eczema and itch appeared, and the patient presented in dermatology department same day.On the treated both sides, abdomen and the back of neck, there was eczema and itch sensation.Left eye was found to be bloodshot.Talion and ointment were prescribed.The situation was not improved, so the patient presented in dermatology department again four days later, then prescribed talion and steroid.Since then, improvement was seen, and the patient presented to hospital ten days post initial symptom.Eye-drops was prescribed for the left eye.No further patient injury reported.
 
Manufacturer Narrative
Additional information: it was reported that 22cm of the right great saphenous vein was treated with 8 treatments administered; 28cm of the left great saphenous vein was treated with 10 treatments administered.The volume of adhesive administered in each leg is unknown.Patient had a follow up consultation 7 weeks post procedure, with the rash and pruritus reported alleviated.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: patient had a follow up consultation 7 weeks after the procedure and the rash and pruritus were alleviated.Image review: four images of received for evaluation.Image 1 shows redness on the patient left and right thigh.Image 2 and 3 show patient left and right thigh.Image 4 shows redness behind the patient neck.Image shows progression of the redness behind patient neck.The redness has improved.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9994830
MDR Text Key188792272
Report Number9612164-2020-01678
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/24/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2021
Device Catalogue NumberSP-101
Device Lot Number55952
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/02/2020
Date Device Manufactured06/05/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-